US FDA flags Dabur's Silvassa plant under Import Alert 66-40; company calls impact insignificant
Dabur India says only a small section of its Silvassa facility is affected by the US FDA's Import Alert 66-40, with domestic products and broader operations unaffected. Management has framed the financial impact as insignificant, but the alert puts a regulatory spotlight on the FMCG major's export-facing manufacturing footprint.
What happened
Dabur India · US FDA issued Import Alert 66-40 on Dabur's Silvassa unit; company says impact is insignificant as only a small part of plant is affected,
Key facts
- Import Alert 66-40
- Rs 2,030 crore NCDs
- £4 million loan
- Rs 720 crore buyback
Why this matters
The alert is a reminder that export-manufacturing compliance is a diligence red flag—stress-test FDA exposure in any FMCG target's plant footprint and price in remediation capex.